首页> 外文OA文献 >Oral Rehydration Therapy in Young Infants less than 3 Months with Acute Diarrhoea and Modeate Dehydration
【2h】

Oral Rehydration Therapy in Young Infants less than 3 Months with Acute Diarrhoea and Modeate Dehydration

机译:口腔补液治疗患有急性腹泻和中度脱水3个月的年轻婴儿

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Oral rehydration therapy (ORT) as an appropriate technology in the treatment of acute diarrhoeal diseases (ADD) has been accepted throughout the world. It has been proved that besides lifesaving, ORT has reduced about 70-80% of the use of intravenous solution and average cost of the treatment of ADD. If there is still problem, question or doubtfulness, is the use of WHO ORS in full concentration for the neonates and young infants less than 3 months of age.During one-year period it has been treated 72 cases of ADD in young infants less than 3 months of age with moderate dehydration. They were divided into 3 groups. The first group was treated with 100 mil kg bw of fluid consisting oftwothirds as WHO ORS in full concentration for 4 hours period and the rest, one-third, was given as plain water for 2 hours period. The second group was treated with kristalyte with the Na concentration of 51 mEq/L and the third group was treated with intravenous Ringer's lactate for 6 hours period.After the end of the study only 18 patients in each group could be matched and evaluated. From clinical observation and laboratory examinations, the result of the treatment in general, statistically shows no significant difference. Diarrhoea and vomiting stopped in all groups on the second day of treatment. Hyponatremia which occurred in 3 patients in Group I and 2 patients each in Group II and III improved  after 6 hours of treatment. Acidosis was corrected in all of the treatment groups in 6 hours period. Weight gain up to 6-9% of body weight on admission was achieved after 6 hours of treatment in all groups. No complication of hypernatremia, convulsion nor hypoglycaemia in all the treatment group.From this study it could be concluded that WHO ORS is quite safe and effective as ORS with low sodium concentration and intravenous treatment, as far as it is given slowly, little by little with a strict supervision.
机译:口服补液治疗(ORT)作为治疗急性腹泻疾病(ADD)的适当技术已被全世界被接受。已经证明,除了救生之外,ORT还减少了静脉内溶液使用的约70-80%和加入治疗的平均成本。如果仍然存在问题,问题或疑问,是使用谁或者在不到3个月的年龄的新生儿和年轻婴儿的全部集中度。在为期一年期间,在中度脱水中,已经治疗了少于3个月的年轻婴儿的72例。它们分为3组。第一个组被100密耳的kg BW处理,该流体组成,因为在全浓度为4小时和剩余的时间,剩下的三分之一,作为纯净水为纯净水。第二组用克里斯塔利特治疗,Na浓度为51meq / L,第三组用静脉内林氏乳酸处理6小时。在研究结束后,每组只有18名患者可以匹配和评估。从临床观察和实验室检查中,治疗结果一般,统计学上显示出没有显着差异。腹泻和呕吐在治疗的第二天的所有群体中停止。在II组和2例患者中发生的低钠血症,II组和III组的2名患者在治疗6小时后改善。在6小时内,在所有治疗组中校正酸性炎。在所有群体治疗6小时后,在入院中获得高达6-9%的体重达6-9%。在所有治疗组中没有复杂性高血症,惊厥或低血糖症。从这项研究开始,可以得出结论,谁或者是嗜钠浓度和静脉治疗的患者是非常安全和有效的,只要它慢慢地,严格的监督略微一点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号